ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00651703
Recruitment Status : Completed
First Posted : April 3, 2008
Last Update Posted : November 15, 2010
Sponsor:
Information provided by:
Cytos Biotechnology AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2009
  Actual Study Completion Date : July 2010